Topical sirolimus 0.1% for treating cutaneous microcystic lymphatic malformations in children and adults (TOPICAL): protocol for a multicenter phase 2, within-person, randomized, double-blind, vehicle-controlled clinical trial

Peer Review reports

Original Submission
19 Jul 2019	Submitted	Original manuscript
9 Sep 2019	Reviewed	Reviewer Report - Kirsty Loudon
27 Sep 2019	Author responded	Author comments - Sophie Leducq
Resubmission - Version 2
27 Sep 2019	Submitted	Manuscript version 2
29 Sep 2019	Reviewed	Reviewer Report - Kirsty Loudon
Resubmission - Version 3
	Submitted	Manuscript version 3
Publishing
29 Sep 2019	Editorially accepted
17 Dec 2019	Article published	10.1186/s13063-019-3767-8

Back to article page